In glioblastoma cells, high levels of TRPM7 expression were observed compared to the differentiated controls, and its downregulation significantly reduced the stem cell markers CD133 and ALDH1 and inhibited two key stem pathways, STAT3 and Notch [102]. The gene discussed is PROM1; the disease is glioblastoma.